Coral Laboratories Limited

BSE: 524506
Coral Laboratories Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24231MH1997PLC422233 Incorporated 06 February 1997 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 524506 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹85.9 Cr
▼ 25.31% YoY
Computed EBITDA · FY 2026
₹25.11 Cr
▼ 28.96% YoY
Net profit · FY 2026
₹16.38 Cr
▼ 32.18% YoY
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹3.57 Cr
Issued & subscribed
Open charges
₹31.05 Cr
Satisfied ₹1.97 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
103
Latest available

About Coral Laboratories Limited

Data last updated: 23 July 2026

Coral Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 06 February 1997, the company has been in operation for over 29 years.

Registered with ROC Mumbai under CIN L24231MH1997PLC422233. Listed on BSE: 524506.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹3.57 Cr. Formerly known as Coral Laboratories Private Limited. It is led by directors including Saurabh Kamlesh Shah and Girish Madanlal Dhameja.

Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹85.9 Cr, a decline of 25.31% compared to the previous year. The net worth stands at ₹209.11 Cr (up 3.93% YoY). Total assets are valued at ₹240.66 Cr (up 4.88% YoY).

The company has a workforce of approximately 103 employees as per the latest available data.

The company is associated with 1 brand - Coral Laboratories. As per MCA filings, the company has open charges of ₹31.05 Cr and satisfied charges of ₹1.97 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website corallab.com.

Company Details of Coral Laboratories Limited
CIN L24231MH1997PLC422233
Registration Number 422233
Incorporation Date 06 February 1997
ROC Mumbai
Listing Status Listed (BSE: 524506)
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Girish Madanlal Dhameja Whole-Time Director Saurabh Kamlesh Shah Director Sushma Shashi Kadkade Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    corallab.com
  • Social Media
    Locked
  • Registered Address
    Shed No. 3B Patanwala Compound, Opp Shreyas Lbs Marg Ghatkopar (West), Mumbai, Maharashtra, India – 400086
  • Industry
    Pharma, Drug Formulation & Development
Company report
Coral Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Coral Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Coral Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Coral Laboratories Limited

Coral Laboratories Limited has one previous CIN (Corporate Identification Number): L24231GJ1997PLC031669. The current CIN is L24231MH1997PLC422233, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24231MH1997PLC422233 Current
L24231GJ1997PLC031669 Previous

Associated Brands with Coral Laboratories Limited

Coral Laboratories Limited operates one associated brand: Coral Laboratories. These brands represent Coral Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Coral Laboratories
Manufacturer of generic drugs corallab.com

Business Activity of Coral Laboratories Limited

Coral Laboratories Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Detailed business activity records for Coral Laboratories Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Coral Laboratories Limited

Coral Laboratories Limited is audited by S C Mehra & Associates LLP (ICAI peer reviewed, certificate valid till 2027-03-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
S C Mehra & Associates LLP (ICAI peer reviewed, certificate valid till 2027-03-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Coral Laboratories Limited

Coral Laboratories Limited is currently managed by 6 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Saurabh Kamlesh Shah Director 28 May 2019 7 Years 2 Months Current
Girish Madanlal Dhameja Whole-Time Director 26 May 2017 9 Years 3 Months Current
Sushma Shashi Kadkade Director 26 May 2017 9 Years 3 Months Current
Rajendrasinh Ajitsinh Rana Director 03 Sep 2021 4 Years 11 Months Current
Malay Sureshkumar Doshi Director 27 May 2021 5 Years 2 Months Current
Pooja Sanjiv Hindia Director 09 Aug 2024 2 Years 0 Months Current
View all directors

Financials of Coral Laboratories Limited FY 2026 filings available

Coral Laboratories Limited reported revenue of ₹85.9 Cr (down 25.31% YoY) for FY 2026.

Revenue · FY 2026
₹85.9 Cr ▼ 25.31%
Profit · FY 2026
₹16.38 Cr ▼ 32.18%
Computed EBITDA · FY 2026
₹25.11 Cr ▼ 28.96%
Revenue₹ Cr · Standalone050100150FY 2019: ₹91 Cr91.1FY 2019FY 2020: ₹71 Cr · -22.5% YoY70.6-22.5%FY 2020FY 2021: ₹97 Cr · +36.8% YoY96.6+36.8%FY 2021FY 2022: ₹76 Cr · -21.7% YoY75.6-21.7%FY 2022FY 2023: ₹78 Cr · +3.3% YoY78.1+3.3%FY 2023FY 2024: ₹84 Cr · +7.1% YoY83.7+7.1%FY 2024FY 2025: ₹115 Cr · +37.5% YoY115+37.5%FY 2025FY 2026: ₹86 Cr · -25.3% YoY85.9-25.3%FY 2026
Net Profit₹ Cr · Standalone0102030FY 2019: ₹10 Cr10.2FY 2019FY 2020: ₹7 Cr · -30.2% YoY7.1-30.2%FY 2020FY 2021: ₹14 Cr · +90.1% YoY13.6+90.1%FY 2021FY 2022: ₹9 Cr · -33.3% YoY9-33.3%FY 2022FY 2023: ₹6 Cr · -28.7% YoY6.4-28.7%FY 2023FY 2024: ₹16 Cr · +145% YoY15.8+145%FY 2024FY 2025: ₹24 Cr · +53% YoY24.2+53%FY 2025FY 2026: ₹16 Cr · -32.2% YoY16.4-32.2%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year02040Q1'25: ₹32 Cr31.7Q1'25Q2'25: ₹32 Cr32.2Q2'25Q3'25: ₹23 Cr23Q3'25Q4'25: ₹28 Cr28.1Q4'25Q1'26: ₹19 Cr · -40.5% YoY18.8-40.5%Q1'26Q2'26: ₹19 Cr · -40.9% YoY19-40.9%Q2'26Q3'26: ₹22 Cr · -6.2% YoY21.6-6.2%Q3'26Q4'26: ₹26 Cr · -5.9% YoY26.5-5.9%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹85.9 Cr ₹115.01 Cr ₹83.66 Cr ₹78.12 Cr ₹75.61 Cr ₹96.57 Cr ₹70.58 Cr ₹91.08 Cr
Other Income ₹9.9 Cr ₹9.11 Cr ₹6.63 Cr ₹6.9 Cr ₹4.81 Cr ₹3.77 Cr ₹5.89 Cr ₹5.16 Cr
Total Income ₹95.8 Cr ₹124.11 Cr ₹90.29 Cr ₹85.01 Cr ₹80.42 Cr ₹100.34 Cr ₹76.47 Cr ₹96.24 Cr
Cost of Materials Consumed ₹39.87 Cr ₹48.14 Cr ₹39.68 Cr ₹41.4 Cr ₹38.35 Cr ₹48.97 Cr ₹38.68 Cr ₹49.23 Cr
Purchases of Stock-in-Trade ₹2.64 Cr ₹1.56 Cr ₹69.52 Lakh ₹70.64 Lakh ₹66.08 Lakh ₹1.15 Cr ₹4.28 Cr ₹1.54 Cr
Changes in Inventories -₹6.97 Cr ₹3.32 Cr -₹3.13 Cr ₹3.64 Cr ₹71.21 Lakh -₹5.05 Lakh -₹2.94 Cr ₹65,000
Employee Benefit Expense ₹15.92 Cr ₹14.74 Cr ₹11.2 Cr ₹11.13 Cr ₹11.23 Cr ₹10.18 Cr ₹9.7 Cr ₹9.84 Cr
Finance Costs ₹17.14 Lakh ₹9.76 Lakh ₹2,000 ₹33.85 Lakh ₹14.11 Lakh ₹4.25 Lakh ₹5.81 Lakh ₹2.3 Lakh
Depreciation & Amortisation ₹2.14 Cr ₹2.01 Cr ₹1.98 Cr ₹2.18 Cr ₹1.99 Cr ₹1.98 Cr ₹2.01 Cr ₹1.9 Cr
Other Expenses ₹19.24 Cr ₹21.01 Cr ₹18.98 Cr ₹17.43 Cr ₹16.45 Cr ₹20.47 Cr ₹15.56 Cr ₹18.2 Cr
Total Expenses ₹72.99 Cr ₹90.87 Cr ₹69.4 Cr ₹76.83 Cr ₹69.53 Cr ₹82.74 Cr ₹67.35 Cr ₹80.73 Cr
Profit Before Exceptional Items & Tax ₹22.8 Cr ₹33.24 Cr ₹20.9 Cr ₹8.19 Cr ₹10.9 Cr ₹17.59 Cr ₹9.12 Cr ₹15.51 Cr
Exceptional Items ₹31.25 Lakh -₹76.96 Lakh -₹16.35 Lakh ₹3.81 Lakh ₹95.94 Lakh ₹1.87 Lakh ₹0 ₹0
Profit Before Tax ₹23.11 Cr ₹32.47 Cr ₹20.73 Cr ₹8.23 Cr ₹11.86 Cr ₹17.61 Cr ₹9.12 Cr ₹15.51 Cr
Total Tax Expense ₹6.73 Cr ₹8.31 Cr ₹4.94 Cr ₹1.78 Cr ₹2.81 Cr ₹4.06 Cr ₹1.99 Cr ₹5.29 Cr
Net Profit ₹16.38 Cr ₹24.16 Cr ₹15.79 Cr ₹6.45 Cr ₹9.05 Cr ₹13.55 Cr ₹7.13 Cr ₹10.22 Cr
Other Comprehensive Income -₹7.94 Cr ₹26.81 Lakh ₹6.91 Cr -₹7.7 Cr ₹10.36 Cr ₹7.42 Cr -₹4.37 Cr -₹11.92 Cr
Total Comprehensive Income ₹8.44 Cr ₹24.42 Cr ₹22.7 Cr -₹1.26 Cr ₹19.41 Cr ₹20.97 Cr ₹2.76 Cr -₹1.71 Cr
EBITDA (computed) ₹25.11 Cr ₹35.35 Cr ₹22.87 Cr ₹10.71 Cr ₹13.03 Cr ₹19.62 Cr ₹11.18 Cr ₹17.43 Cr
Basic EPS ₹45.85 ₹67.61 ₹44.19 ₹18.04 ₹25.32 ₹37.94 ₹19.96 ₹8.75
Diluted EPS ₹45.85 ₹67.61 ₹44.19 ₹18.04 ₹0.00 ₹0.00 ₹19.96 ₹8.75
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹240.66 Cr ₹229.46 Cr ₹205.68 Cr ₹174.35 Cr ₹189.9 Cr ₹167.54 Cr ₹144.29 Cr ₹135.77 Cr
Non-current Assets ₹63.7 Cr ₹52.92 Cr ₹51.83 Cr ₹50.81 Cr ₹59.09 Cr ₹56.7 Cr ₹48.45 Cr ₹52.14 Cr
Current Assets ₹176.97 Cr ₹176.55 Cr ₹153.85 Cr ₹123.54 Cr ₹130.8 Cr ₹110.84 Cr ₹95.83 Cr ₹83.63 Cr
Property, Plant & Equipment ₹43.17 Cr ₹21.74 Cr ₹23.27 Cr ₹24.28 Cr ₹22.77 Cr ₹20.41 Cr ₹21.49 Cr ₹22.11 Cr
Inventories ₹20.53 Cr ₹9.87 Cr ₹15.16 Cr ₹12.5 Cr ₹18.36 Cr ₹21.67 Cr ₹19.3 Cr ₹16.17 Cr
Trade Receivables ₹29.43 Cr ₹33.64 Cr ₹28.19 Cr ₹23.42 Cr ₹38.11 Cr ₹39.16 Cr ₹34.41 Cr ₹30.32 Cr
Cash & Equivalents ₹1.37 Cr ₹3.41 Cr ₹2.07 Cr ₹6.13 Cr ₹2.51 Cr ₹2.32 Cr ₹1.11 Cr ₹2.97 Cr
Equity (Net Worth) ₹209.11 Cr ₹201.21 Cr ₹177.5 Cr ₹154.8 Cr ₹156.05 Cr ₹136.64 Cr ₹115.67 Cr ₹113.77 Cr
Equity Share Capital ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹4.33 Cr ₹3.56 Cr ₹0 ₹0 ₹6.04 Cr ₹6.25 Cr ₹5.91 Cr ₹1.44 Cr
Total Debt (computed) ₹4.33 Cr ₹3.56 Cr ₹0 ₹0 ₹6.04 Cr ₹6.25 Cr ₹5.91 Cr ₹1.44 Cr
Current Liabilities ₹27.31 Cr ₹24.96 Cr ₹24.9 Cr ₹11.86 Cr ₹25.52 Cr ₹27.79 Cr ₹25.09 Cr ₹18.02 Cr
Total Liabilities ₹31.55 Cr ₹28.26 Cr ₹28.18 Cr ₹19.55 Cr ₹33.84 Cr ₹30.9 Cr ₹28.62 Cr ₹22 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹15.62 Cr -₹1.22 Cr -₹5.46 Cr ₹12.67 Cr ₹6.08 Cr
Investing Cash Flow -₹17.71 Cr -₹15.19 Lakh ₹1.4 Cr -₹2.61 Cr -₹6.05 Cr
Financing Cash Flow ₹5.98 Lakh ₹2.71 Cr ₹66,000 -₹6.43 Cr ₹14.91 Lakh
Capital Expenditure ₹21.09 Cr ₹2.95 Cr ₹99.1 Lakh ₹1.95 Cr ₹5.55 Cr
Free Cash Flow (computed) -₹5.48 Cr -₹4.17 Cr -₹6.46 Cr ₹10.72 Cr ₹53.54 Lakh
Dividends Paid ₹53.59 Lakh ₹71.45 Lakh ₹0 ₹0 ₹0
Net Change in Cash -₹2.03 Cr ₹1.33 Cr -₹4.06 Cr ₹3.62 Cr ₹18.15 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹26.48 Cr ₹21.56 Cr ₹19.03 Cr ₹18.82 Cr ₹28.13 Cr ₹22.99 Cr ₹32.23 Cr ₹31.66 Cr
Other Income ₹2.65 Cr ₹2.49 Cr ₹2.71 Cr ₹2.05 Cr ₹2.48 Cr ₹2.52 Cr ₹2.54 Cr ₹1.56 Cr
Total Income ₹29.13 Cr ₹24.06 Cr ₹21.74 Cr ₹20.87 Cr ₹30.62 Cr ₹25.51 Cr ₹34.77 Cr ₹33.22 Cr
Cost of Materials Consumed ₹11.3 Cr ₹12.93 Cr ₹7.31 Cr ₹8.33 Cr ₹11.39 Cr ₹8.98 Cr ₹15.97 Cr ₹11.8 Cr
Purchases of Stock-in-Trade ₹26.02 Lakh ₹75.06 Lakh ₹80.97 Lakh ₹81.89 Lakh ₹42.54 Lakh ₹16.09 Lakh ₹27.31 Lakh ₹70.21 Lakh
Changes in Inventories -₹99.3 Lakh -₹5 Cr -₹56.54 Lakh -₹41.46 Lakh ₹2.75 Cr ₹32.3 Lakh -₹68.8 Lakh ₹92.62 Lakh
Employee Benefit Expense ₹4.39 Cr ₹4.4 Cr ₹3.7 Cr ₹3.42 Cr ₹3.83 Cr ₹3.38 Cr ₹3.93 Cr ₹3.59 Cr
Finance Costs ₹1.01 Lakh ₹8,000 ₹10.27 Lakh ₹5.79 Lakh ₹3.86 Lakh ₹1.93 Lakh ₹1.13 Lakh ₹2.84 Lakh
Depreciation & Amortisation ₹54.17 Lakh ₹68.69 Lakh ₹45.22 Lakh ₹45.32 Lakh ₹50.61 Lakh ₹50.15 Lakh ₹50.9 Lakh ₹49.39 Lakh
Other Expenses ₹5.32 Cr ₹6.59 Cr ₹2.85 Cr ₹4.48 Cr ₹7.05 Cr ₹3.82 Cr ₹6.24 Cr ₹3.9 Cr
Total Expenses ₹20.83 Cr ₹20.36 Cr ₹14.65 Cr ₹17.15 Cr ₹25.99 Cr ₹17.19 Cr ₹26.24 Cr ₹21.44 Cr
Profit Before Exceptional Items & Tax ₹8.3 Cr ₹3.7 Cr ₹7.09 Cr ₹3.72 Cr ₹4.62 Cr ₹8.31 Cr ₹8.53 Cr ₹11.77 Cr
Exceptional Items -₹99,000 ₹0 ₹32.25 Lakh ₹0 -₹76.96 Lakh ₹0 ₹0 ₹0
Profit Before Tax ₹8.29 Cr ₹3.7 Cr ₹7.42 Cr ₹3.72 Cr ₹3.85 Cr ₹8.31 Cr ₹8.53 Cr ₹11.77 Cr
Total Tax Expense ₹3.06 Cr ₹92 Lakh ₹1.6 Cr ₹1.16 Cr ₹1.02 Cr ₹2.17 Cr ₹2.15 Cr ₹2.97 Cr
Net Profit ₹5.22 Cr ₹2.78 Cr ₹5.82 Cr ₹2.56 Cr ₹2.83 Cr ₹6.14 Cr ₹6.38 Cr ₹8.8 Cr
Other Comprehensive Income -₹9.42 Cr -₹2.02 Cr -₹2.13 Cr ₹5.63 Cr -₹12.57 Cr ₹1.25 Cr ₹2.84 Cr ₹8.74 Cr
Total Comprehensive Income -₹4.2 Cr ₹76.03 Lakh ₹3.69 Cr ₹8.2 Cr -₹9.74 Cr ₹7.4 Cr ₹9.22 Cr ₹17.54 Cr
EBITDA (computed) ₹8.85 Cr ₹4.38 Cr ₹7.65 Cr ₹4.23 Cr ₹5.17 Cr ₹8.84 Cr ₹9.05 Cr ₹12.3 Cr
Basic EPS ₹14.62 ₹7.77 ₹16.29 ₹7.18 ₹7.91 ₹17.20 ₹17.86 ₹24.64
Diluted EPS ₹14.62 ₹7.77 ₹16.29 ₹7.18 ₹7.91 ₹17.20 ₹17.86 ₹24.64
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Coral Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Coral Laboratories Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 71.51%, retail and other public shareholders hold 28.49% of Coral Laboratories Limited. The company had 4,084 shareholders on record.

Promoters: 71.51%Retail & Others: 28.49%
Mar 2026
QUARTER
71.51% Promoters
28.49% Retail & Others
Promoter holding - history
Now 71.51% · Mar 2026High 71.51% · Jun 2023Low 71.51% · Jun 2023
70%70.8%71.5%72.3%73%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 71.51%Sep 2023: 71.51%Dec 2023: 71.51%Mar 2024: 71.51%Jun 2024: 71.51%Sep 2024: 71.51%Dec 2024: 71.51%Mar 2025: 71.51%Jun 2025: 71.51%Sep 2025: 71.51%Dec 2025: 71.51%Mar 2026: 71.51%71.51%71.51%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters71.51%71.51%71.51%71.51%71.51%71.51%
Public28.49%28.49%28.49%28.49%28.49%28.49%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters71.51%71.51%71.51%
Public28.49%28.49%28.49%
Promoter change (YoY, %pts)+0.00+0.00-

Charges & Borrowings of Coral Laboratories Limited

Open charges
₹31.05 Cr
Satisfied charges
₹1.97 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹31.05 Cr
Latest charge details
DateLenderAmountStatus
17 Jan 2019 Hdfc Bank Limited ₹23.35 Cr Open
28 Dec 2006 Hdfc Bank Limited ₹7.7 Cr Open
13 Jul 2000 Bank of Baroda ₹1.97 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Coral Laboratories Limited

Coral Laboratories Limited has a workforce of 103 employees as of Mar 29, 2025.

Employee count
103
Active EPFO establishments
2
Employee growth
13.19%
Premium access

Employee and EPFO history for Coral Laboratories Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Coral Laboratories Limited

Premium access

GST registrations and filing compliance for Coral Laboratories Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Coral Laboratories Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Coral Laboratories Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Coral Laboratories Limited

Premium access

MSME payment history for Coral Laboratories Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Coral Laboratories Limited

Premium access

Corporate group structure for Coral Laboratories Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Coral Laboratories Limited

Premium access

MCA filings and documents for Coral Laboratories Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Coral Laboratories Limited

Directors
06 May 2026
Diwakar Unnikrishana Menon was appointed as a Company Secretary on 06 May 2026 & has been associated with this company since 3 months 21 days.
Activity
26 Sep 2025
Coral Laboratories Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Coral Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
09 Aug 2024
Pooja Sanjiv Hindia was appointed as a Director on 09 Aug 2024 & has been associated with this company since 2 years 16 days.
Charges
17 Feb 2023
A charge with Hdfc Bank Limited of Rs. 23.35 Cr registered on 17 Jan 2019 with Charge ID 100240261 was modified on 17 Feb 2023.
Directors
03 Sep 2021
Rajendrasinh Ajitsinh Rana was appointed as a Director on 03 Sep 2021 & has been associated with this company since 4 years 11 months.

Frequently Asked Questions about Coral Laboratories Limited

Coral Laboratories Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 06 February 1997 (29+ years old) and is registered under CIN L24231MH1997PLC422233. Listed on BSE: 524506. The company has 103 employees.

Coral Laboratories Limited reported revenue of ₹85.9 Cr for FY 2026 (down 25.31% YoY) based on standalone BSE filings.

The current directors of Coral Laboratories Limited are:

The primary industry of Coral Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Coral Laboratories Limited is listed on BSE with code 524506.

Coral Laboratories Limited can be reached at the registered office: Shed No. 3B Patanwala Compound, Opp Shreyas Lbs Marg Ghatkopar West, Mumbai, Maharashtra, India – 400086, or through the website corallab.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available